drugset / Trial / NCT05493735

Lidocaine for Pessary Check Pain Reduction

NCT05493735 ↗

Phase 3 Completed 66 enrolled University of South Florida
RandomizedParallel-groupSingle-blindPrevention

Summary

The primary objective of this study is to estimate the effect of lidocaine jelly on patient pain at the time of office pessary removal.

Timeline

Start
2022-09-08
Primary completion
2023-06-23
Completion
2023-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Topical